Citation Impact
Citing Papers
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
2000 Standout
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
2012 Standout
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
2003 StandoutScience
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
2017 Standout
Comprehensive molecular portraits of human breast tumours
2012 StandoutNature
Triple-Negative Breast Cancer
2010 Standout
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
2002 Standout
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
2015 Standout
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma
1999 Standout
Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial
2009
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
2014 Standout
Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian Cancer
2001
BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer
2000
Ovarian cancer
2014 Standout
Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma
2004
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
2009 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Survival of Californian women with epithelial ovarian cancer, 1994–1996: a population-based study
2003
Current Management Strategies for Ovarian Cancer
2007
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
2010 Standout
Do abused children become abusive parents?
1987
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
DNA Damage, Aging, and Cancer
2009 Standout
Adult attachment representations, parental responsiveness, and infant attachment: A meta-analysis on the predictive validity of the Adult Attachment Interview.
1995 Standout
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
2011 Standout
Concomitant radiation therapy and chemotherapy in the treatment of advanced squamous carcinoma of the lower female genital tract
1989
A distinct molecular profile associated with mucinous epithelial ovarian cancer
2006
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Survival benefit for patients with advanced-stage transitional cell carcinomas vs. other subtypes of ovarian carcinoma after chemotherapy with platinum and paclitaxel
2005
Stem cell origins of leukaemia and curability
1993
Corporal punishment by parents and associated child behaviors and experiences: A meta-analytic and theoretical review.
2002 Standout
Combined Carboplatin plus Ifosfamide and Cisplatin in Patients with Advanced Ovarian Carcinoma. A Phase I–II Study
1998
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
2012 Standout
Recent progress in the diagnosis and treatment of ovarian cancer
2011
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
2010 Standout
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
2009 Standout
Estrogen replacement therapy for ovarian carcinoma survivors
1999
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
1997 Standout
Hypothalamic Hormones and Cancer
2001 Nobel
Using sulfuramidimidoyl fluorides that undergo sulfur(vi) fluoride exchange for inverse drug discovery
2020 StandoutNobel
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
2010 Standout
Population BRCA1 and BRCA2 Mutation Frequencies and Cancer Penetrances: A Kin–Cohort Study in Ontario, Canada
2006
BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum*1
1998
Cancer of the Ovary
2004 Standout
Long-term consequences of childhood physical abuse.
1993 Standout
Cardiotoxicity of cytotoxic drugs
2003
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
2007
The child-abusing parent: A psychological review.
1972
Current Management Strategies for Ovarian Cancer
2007
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Clinical Features of Hypersensitivity Reactions to Carboplatin
1999
Treatment of 29 patients with bulky squamous cell carcinoma of the cervix with simultaneous cisplatin, 5-fluorouracil, and split-course hyperfractionated radiation therapy
1990
The Human Ecology of Child Maltreatment: A Conceptual Model for Research
1977
The role of radiotherapy in cancer treatment
2005 Standout
On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1
2012 Standout
Personal space: Where we now stand.
1983 Standout
Three theoretical models of child abuse: A critical review
1978
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
Primary Vaginal Cancer
1998
Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control Study
2005 Standout
The Determinants of Parenting: A Process Model
1984 Standout
Fallopian Tube and Primary Peritoneal Carcinomas Associated With BRCA Mutations
2003
Platinum resistance: Laboratory findings and clinical implications
1993
The Cycle of Violence
1989 StandoutScience
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
2006 Standout
Behavior Problem Indices
1978
Multimodal assessment of impulsiveness in abusing, neglecting, and nonmaltreating mothers and their preschool children.
1986
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation
2014 Standout
Works of Peter Blake being referenced
The physically abused child: Focus on prevention
1969
Contribution ofBRCA1Mutations to Ovarian Cancer
1997
A new treatment for endometrial cancer with gonadotrophin releasing‐hormone analogue
1991
Endometrial carcinoma: Adjuvant locoregional therapy
1996
Vaginal sarcoma: the Royal Marsden experience
1994
Combining platinum, paclitaxel and anthracycline in patients with advanced gynaecological malignancy
2000
Hypersensitivity reactions to cisplatin and carboplatin — A report on six cases
1992
Cisplatin and carboplatin in combination for the treatment of stage IV ovarian carcinoma
1991
Surgery following chemotherapy and radiotherapy for advanced carcinoma of the cervix
1984
Hormone replacement therapy and survival after surgery for ovarian cancer.
1991
Natural History of Stage IV Epithelial Ovarian Cancer
1999
Mucinous Epithelial Ovarian Cancer: A Separate Entity Requiring Specific Treatment
2004
Combined radiotherapy and chemotherapy for advanced carcinoma of the cervix
1986
Can Patients With Relapsed, Previously Untreated, Stage I Epithelial Ovarian Cancer Be Successfully Treated With Salvage Therapy?
2003